


Healthcare News Roundup: FDA
HSMN NewsFeed - 23 Apr 2008
Stem Cell Therapeutics Corp. Receives "May Proceed" From FDA for Its Phase IIb Clinical Stroke Trial and IND
Stem Cell Therapeutics Corp. Receives "May Proceed" From FDA for Its Phase IIb Clinical Stroke Trial and IND
HSMN NewsFeed - 22 Apr 2008
Cimzia(R) Approved in the US for the Treatment of Moderate to Severe Crohn's Disease
Cimzia(R) Approved in the US for the Treatment of Moderate to Severe Crohn's Disease
HSMN NewsFeed - 22 Apr 2008
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
HSMN NewsFeed - 21 Apr 2008
Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
HSMN NewsFeed - 21 Apr 2008
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
HSMN NewsFeed - 21 Apr 2008
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
HSMN NewsFeed - 18 Apr 2008
Akorn, Inc. Announces FDA Approval of Diclofenac Sodium Ophthalmic Solution 0.1%
Akorn, Inc. Announces FDA Approval of Diclofenac Sodium Ophthalmic Solution 0.1%
HSMN NewsFeed - 17 Apr 2008
FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.
FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.
HSMN NewsFeed - 17 Apr 2008
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
HSMN NewsFeed - 17 Apr 2008
Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Influenza A+B Test
Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Influenza A+B Test
HSMN NewsFeed - 17 Apr 2008
Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
HSMN NewsFeed - 16 Apr 2008
FDA Approves Medtronic's Talent(TM) Abdominal Stent Graft for Repairing Aortic Aneurysms
FDA Approves Medtronic's Talent(TM) Abdominal Stent Graft for Repairing Aortic Aneurysms
HSMN NewsFeed - 16 Apr 2008
Akorn, Inc. Announces FDA Approval of Ofloxacin Ophthalmic Solution USP, 0.3%
Akorn, Inc. Announces FDA Approval of Ofloxacin Ophthalmic Solution USP, 0.3%
HSMN NewsFeed - 15 Apr 2008
Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
HSMN NewsFeed - 15 Apr 2008
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
HSMN NewsFeed - 15 Apr 2008
BSD Medical Submits 510(k) Premarket Notification for MicroThermX(R)-100 Microwave Ablation System
BSD Medical Submits 510(k) Premarket Notification for MicroThermX(R)-100 Microwave Ablation System
HSMN NewsFeed - 15 Apr 2008
Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
HSMN NewsFeed - 7 Apr 2008
BRAHMS Receives FDA Clearance to Market Automated Procalcitonin (PCT) Test
BRAHMS Receives FDA Clearance to Market Automated Procalcitonin (PCT) Test
HSMN NewsFeed - 4 Apr 2008
iCAD Receives FDA Approval for Its SecondLook Digital for Use With Fuji's Digital Mammography System
iCAD Receives FDA Approval for Its SecondLook Digital for Use With Fuji's Digital Mammography System
HSMN NewsFeed - 2 Apr 2008
Imaging3 Receives FDA Approval to Distribute the Dominion Vi Scanner Under FDA (IDE) Regulations
Imaging3 Receives FDA Approval to Distribute the Dominion Vi Scanner Under FDA (IDE) Regulations
HSMN NewsFeed - 1 Apr 2008
Supratek's lead compound SP1049C is granted Orphan Drug Designation for the treatment of gastric cancer.
Supratek's lead compound SP1049C is granted Orphan Drug Designation for the treatment of gastric cancer.
HSMN NewsFeed - 28 Mar 2008
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
HSMN NewsFeed - 28 Mar 2008
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
HSMN NewsFeed - 28 Mar 2008
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
HSMN NewsFeed - 25 Mar 2008
Pioneer(R) Surgical Technology Receives 510(k) Clearance to Market Next Generation Pedicle Screw System
Pioneer(R) Surgical Technology Receives 510(k) Clearance to Market Next Generation Pedicle Screw System
HSMN NewsFeed - 25 Mar 2008
Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer
Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer
HSMN NewsFeed - 25 Mar 2008
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
HSMN NewsFeed - 24 Mar 2008
CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
HSMN NewsFeed - 24 Mar 2008
Pro-Pharmaceuticals Announces DAVANAT(R) Regimen Approved to Treat Breast Cancer Patient
Pro-Pharmaceuticals Announces DAVANAT(R) Regimen Approved to Treat Breast Cancer Patient
HSMN NewsFeed - 20 Mar 2008
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
HSMN NewsFeed - 20 Mar 2008
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
HSMN NewsFeed - 20 Mar 2008
Smiths Medical Receives FDA Clearance for Next Generation CADD(R)-Solis Ambulatory Infusion System
Smiths Medical Receives FDA Clearance for Next Generation CADD(R)-Solis Ambulatory Infusion System
HSMN NewsFeed - 20 Mar 2008
PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
HSMN NewsFeed - 19 Mar 2008
Akorn-Strides, LLC Announces FDA Approval for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL
Akorn-Strides, LLC Announces FDA Approval for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL
HSMN NewsFeed - 18 Mar 2008
Immunomedics' Milatuzumab Receives FDA Orphan Drug Designation for Therapy of Multiple Myeloma
Immunomedics' Milatuzumab Receives FDA Orphan Drug Designation for Therapy of Multiple Myeloma
HSMN NewsFeed - 18 Mar 2008
AtriCure's Coolrail(TM) Linear Ablation Pen Receives FDA 510(k) Clearance
AtriCure's Coolrail(TM) Linear Ablation Pen Receives FDA 510(k) Clearance
HSMN NewsFeed - 18 Mar 2008
FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections
FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections
HSMN NewsFeed - 18 Mar 2008
FDA issues Approvable Letter for ceftobiprole, a new anti-MRSA broad-spectrum antibiotic
FDA issues Approvable Letter for ceftobiprole, a new anti-MRSA broad-spectrum antibiotic
HSMN NewsFeed - 17 Mar 2008
Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
HSMN NewsFeed - 13 Mar 2008
Hawthorn Pharmaceuticals, Inc. Receives FDA Approval on Granisol(TM) Oral Solution
Hawthorn Pharmaceuticals, Inc. Receives FDA Approval on Granisol(TM) Oral Solution
HSMN NewsFeed - 13 Mar 2008
FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System
FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System
HSMN NewsFeed - 12 Mar 2008
VertiFlex Introduces the First Ever Percutaneous Dual Rod Accepting Polyaxial Screw
VertiFlex Introduces the First Ever Percutaneous Dual Rod Accepting Polyaxial Screw
HSMN NewsFeed - 12 Mar 2008
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
HSMN NewsFeed - 11 Mar 2008
Santarus Announces Submission of New Drug Application by Schering-Plough for ZEGERID Branded OTC Product
Santarus Announces Submission of New Drug Application by Schering-Plough for ZEGERID Branded OTC Product
HSMN NewsFeed - 10 Mar 2008
Life Spine Adds New Lynx(TM) Cross Connector to Its Lumbar Fixation Offering
Life Spine Adds New Lynx(TM) Cross Connector to Its Lumbar Fixation Offering
HSMN NewsFeed - 7 Mar 2008
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
HSMN NewsFeed - 7 Mar 2008
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
HSMN NewsFeed - 7 Mar 2008
Sorin Group Announces FDA Approval of New Defibrillation Leads Range: ISOLINE(TM)
Sorin Group Announces FDA Approval of New Defibrillation Leads Range: ISOLINE(TM)
HSMN NewsFeed - 2 Mar 2008
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
HSMN NewsFeed - 28 Feb 2008
FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
HSMN NewsFeed - 28 Feb 2008
CAS Medical Systems, Inc. Announces FDA 510(k) Clearance for Neonatal FORE-SIGHT Cerebral Oximeter
CAS Medical Systems, Inc. Announces FDA 510(k) Clearance for Neonatal FORE-SIGHT Cerebral Oximeter
